Osteocrin ameliorates adriamycin nephropathy via p38 mitogen-activated protein kinase inhibition.

MLA

Handa, Takaya, et al. “Osteocrin Ameliorates Adriamycin Nephropathy via P38 Mitogen-Activated Protein Kinase Inhibition.” Scientific Reports, vol. 11, no. 1, Nov. 2021, p. 21835. EBSCOhost, https://doi.org/10.1038/s41598-021-01095-8.

APA

Handa, T., Mori, K. P., Ishii, A., Ohno, S., Kanai, Y., Watanabe-Takano, H., Yasoda, A., Kuwabara, T., Takahashi, N., Mochizuki, N., Mukoyama, M., Yanagita, M., & Yokoi, H. (2021). Osteocrin ameliorates adriamycin nephropathy via p38 mitogen-activated protein kinase inhibition. Scientific Reports, 11(1), 21835. https://doi.org/10.1038/s41598-021-01095-8

Chicago

Handa, Takaya, Keita P Mori, Akira Ishii, Shoko Ohno, Yugo Kanai, Haruko Watanabe-Takano, Akihiro Yasoda, et al. 2021. “Osteocrin Ameliorates Adriamycin Nephropathy via P38 Mitogen-Activated Protein Kinase Inhibition.” Scientific Reports 11 (1): 21835. doi:10.1038/s41598-021-01095-8.